There are several versions of Valganciclovir/Valganciclovir

As an important antiviral drug, Valganciclovir has multiple versions and different brands on the market. The main differences lie in its manufacturer, sales region and possible price differences. However, there is no significant difference between these versions in terms of drug composition, efficacy, and safety.

The original drug of valganciclovir was developed by Roche Pharmaceuticals (F.Hoffmann-La Roche AG), also known as Vancevir, and is sold globally. Original drugs are usually developed by innovative drug companies and are supported by clinical trial data. Their efficacy and safety are highly recognized. In the domestic market, the price of original drugs is relatively high. In addition, Roche Pharmaceuticals is also selling it in Turkey, India, Switzerland and other regions. This version is consistent with the original drug in terms of ingredients and efficacy, but the price may be more affordable.

Valganciclovir is used to treat cytomegalovirus (CMV) retinitis in patients diagnosed with acquired immunodeficiency syndrome (AIDS). Valganciclovir is a prodrug of ganciclovir, a synthetic analog of2′-deoxyguanosine. Its structure is the same as ganciclovir, except that an L-valyl ester is added to the 5' end of the incomplete deoxyribose ring. Valine both increases the absorption of drugs in the intestines and increases the bioavailability of drugs after they are absorbed.

Regarding which brand of valganciclovir is better, this involves individual patient differences and actual conditions. When choosing drugs, patients should consult professional doctors and choose appropriate drugs based on their own condition, medical history and physical condition. At the same time, you can refer to the reputation of the drug manufacturer, clinical trial data of the drug, drug quality supervision and other factors to comprehensively consider choosing the appropriate valganciclovir product.